Key RNAi-Based Drugs in the Clinic
November 12, 2009
Key RNAi-Based Drugs in the Clinic
Overview of key RNAi-based therapeutics currently in human trials
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Key RNAi-Based Drugs in the Clinic
April 29, 2010 / Gene Silencing News - Despite Potential of RNAi, Companies in the Space Keep Pipelines Focused
March 11, 2010 / Gene Silencing News - RNAi Drugs Field Sees Candidate Failures as More Drugs Enter the Clinic
November 17, 2011 / Gene Silencing News - For Some RNAi Rx Shops, Industry Deals with Bigger Players are Par for the Course
August 20, 2009 / Gene Silencing News - Alnylam Reports Positive Phase I Data on ATTR Drug; Sees Pfizer Drug Setback as FDA Guide
July 19, 2012 / Gene Silencing News